Carvedilol Tablet, Film Coated
Product Images NDC 65862-144

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 65862-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)

A survival analysis line graph titled 'Survival Analysis for COPERNICUS (Intent-to-Treat)' showing mortality percentage over 21 months. The chart compares mortality between two groups: Placebo and Carvedilol, with the Placebo group showing higher mortality rates over time. The p-value indicated is 0.0014, suggesting statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)

A forest plot titled 'Effects on Mortality for Subgroups in COPERNICUS' showing hazard ratios for various patient subgroups including men, women, different age groups, races, diabetic status, ischemic status, heart rate levels, systolic blood pressure levels, spironolactone use, and overall patients. Horizontal lines depict confidence intervals around each hazard ratio point estimate.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)

A survival analysis line graph titled 'Survival Analysis for CAPRICORN (Intent-to-Treat)' showing mortality percentage over 24 months. Two curves compare mortality rates between placebo and carvedilol groups, with mortality percentage on the y-axis and months on the x-axis. A P-value of 0.03 is noted on the graph.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)

A figure titled 'Effects on Mortality for Subgroups in CAPRICORN' presenting two forest plots comparing hazard ratios across various subgroups such as age, gender, timing of randomization post-MI, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA for MI, presence of CHF, diuretic use, angina, hypertension, diabetes, heart rate, systolic blood pressure, and overall patient group. Each subgroup compares hazard ratios around a reference line at 1.0.*

FDA Label Image

Package Label-principal Display Panel (3.125 mg (100 Tablet Bottle))

Label for Carvedilol Tablets USP 3.125 mg, film-coated tablets from Aurobindo Pharma Limited. The label indicates prescription use, contains storage instructions, and lists distributor information including address and manufacturing origin as India. The package size is 100 tablets. The label also includes dosage and safety note placeholders and a barcode.*

FDA Label Image

Package Label-principal Display Panel (6.25 mg (100 Tablet Bottle))

Label of Carvedilol Tablets USP 6.25 mg film-coated tablets, packaged as 100 tablets. Distributed by Aurobindo Pharma USA, Inc. The label includes dosage instructions, storage conditions (20° to 25°C), and safety warnings. The product is made in India by Aurobindo Pharma Limited.*

FDA Label Image

Package Label-principal Display Panel (12.5 mg (100 Tablet Bottle))

Label for Carvedilol Tablets, USP 12.5 mg film-coated tablets by Aurobindo Pharma Limited. The label states prescription use only and includes storage instructions (20° to 25°C) and dispensing cautions. The package contains 100 tablets, with distribution by Aurobindo Pharma USA, Inc. Made in India. Includes a barcode and a designated coding area.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablet Bottle))

Carvedilol Tablets USP 25 mg film-coated tablet label by Aurobindo Pharma Limited. The label indicates a package size of 100 tablets with storage instructions, distribution details for Aurobindo Pharma USA, Inc., and dosage strength. The label is designed for prescription use and includes a barcode for product identification.*

FDA Label Image

Chemical Structure (Carvedilol Str)

Chemical structure of carvedilol showing its molecular arrangement including aromatic rings, hydroxyl group, and ether linkages typical of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.